Neuren Pharmaceuticals Stock Quote NEU - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

14.22

Bid

14.05

Ask

14.20

Volume

1,328,906

13.63 Day's Range 15.24

10.02 52 Week Range 170.09

Market Cap

1.816B

Previous Close

13.56

Open

13.65

Last Trade

230

14.19

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

451,459

Shares Outstanding

127,695,676

Dividend Yield

PE Ratio

11.56

Earnings Per Share (EPS)

1.23

Revenue

231.94M

Net Profit

157.08M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.neurenpharma.com

Headquarters

Auckland, Nzl

Founded

Neuren Pharmaceuticals Limited is listed in the Pharmaceutical Preparations sector of the Australian Stock Exchange with ticker NEU. The last closing price for Neuren Pharmaceuticals was AUD13.56. Over the last year, Neuren Pharmaceuticals shares have traded in a share price range of AUD 10.02 to AUD 170.09.

Neuren Pharmaceuticals currently has 127,695,676 shares outstanding. The market capitalization of Neuren Pharmaceuticals is AUD1.73 billion. Neuren Pharmaceuticals has a price to earnings ratio (PE ratio) of 11.56.

ACADIA Pharmaceuticals & Neuren Pharmaceuticals Announce Rare Pediatric Disease Designation for Trofinetide for the Treatment...

With No Approved Treatments in Rett Syndrome, FDA Decision Highlights Significant Unmet Need ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) and Neuren Pharmaceuticals Limited (ASX: NEU) announced...

FDA Grants Orphan Drug Designation for Neuren's NNZ-2591 to Treat Angelman, Phelan-McDermid and Pitt Hopkins Syndromes

Neuren Pharmaceuticals (ASX: NEU) today announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to Neuren’s NNZ-2591 for the treatment of Angelman syndrome...

Positive Phase 2 Study Results of Trofinetide in Pediatric Rett Syndrome Published in Neurology, the Medical Journal of the A...

-- Statistically Significant Improvement Indicates Trofinetide’s Potential for Treating Rett Syndrome-- Trofinetide for Rett Syndrome has Fast Track Status and Orphan Drug Designation in...

ACADIA Pharmaceuticals & Neuren Pharmaceuticals Announce Exclusive License Agreement for the North American Development & Com...

-ACADIA plans to initiate a Phase 3 study of trofinetide for the treatment of Rett syndrome, a rare neurodevelopmental congenital CNS disorder, in the second half of 2019 -Neuren...

American Stock Exchange to Trade Options on Five New Securities

NEW YORK, April 12 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) will launch trading in options on Thursday, April 13, 2006 on the following Nasdaq Stock Market and New York Stock...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.73	5.4114158636	13.49	15.24	13.11	339512	13.61226376	DE
4	-0.98	-6.44736842105	15.2	16.08	13.11	477262	14.42460652	DE
12	-6.23	-30.4645476773	20.45	170.09	13.11	451459	16.84088264	DE
26	-6.22	-30.4305283757	20.44	170.09	13.11	434457	18.64849639	DE
52	3.37	31.0599078341	10.85	170.09	10.02	502212	18.03459928	DE
156	12.17	593.658536585	2.05	170.09	1.625	444947	12.10056339	DE
260	12.05	555.299539171	2.17	170.09	0.965	314792	10.4878283	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MTHOMithril Silver and Gold Ltd	AUD 0.16 (135.29%)	1.36M
MTHMithril Silver and Gold Ltd	AUD 0.36 (75.61%)	15.73M
TX3Trinex Minerals Ltd	AUD 0.003 (50.00%)	75k
SMSStar Minerals Limited	AUD 0.049 (48.48%)	1.97M
BGEBridge SaaS Ltd	AUD 0.014 (40.00%)	250k
SMXSecurity Matters Limited	AUD 0.03 (-88.46%)	1.27M
NTIOANeurotech International Limited	AUD 0.003 (-40.00%)	271.81k
HZROHazer Group Limited	AUD 0.02 (-33.33%)	5.46k
TMGODTrigg Minerals Ltd	AUD 0.004 (-33.33%)	7.44M
RBRRBR Group Limited	AUD 0.0015 (-25.00%)	8.25M
RSGResolute Mining Limited	AUD 0.71 (-3.73%)	172.2M
REDRed 5 Limited	AUD 0.335 (1.52%)	134.21M
CXOCore Lithium Ltd	AUD 0.105 (5.00%)	108.2M
STXStrike Energy Limited	AUD 0.22 (-2.22%)	101.35M
SPRSpartan Resources Limited	AUD 1.36 (3.42%)	77.15M